Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes - Wikidata - awgldk - TriplyDB

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

http://www.wikidata.org/entity/Q21195193

about

Minireview: prolactin regulation of adult stem cells Screening and functional analysis of a differential protein profile of human breast cancer The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.Linking signaling pathways to transcriptional programs in breast cancer.Hypothesis: neuroendocrine mechanisms (hypothalamus-growth hormone-STAT5 axis) contribute to sex bias in pulmonary hypertension.Modeling prolactin actions in breast cancer in vivo: insights from the NRL-PRL mouse.Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism.Global profiling of prolactin-modulated transcripts in breast cancer in vivo.Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity Prolactin Pro-Differentiation Pathway in Triple Negative Breast Cancer: Impact on Prognosis and Potential Therapy Validation of tumor protein marker quantification by two independent automated immunofluorescence image analysis platforms.Differentiation of cancer cells in two-dimensional and three-dimensional breast cancer models by Raman spectroscopy.Prolactin activates ERα in the absence of ligand in female mammary development and carcinogenesis in vivo Prolactin receptor expression and breast cancer: relationships with tumor characteristics among pre- and post-menopausal women in a population-based case-control study from Poland.Prolactin suppresses a progestin-induced CK5-positive cell population in luminal breast cancer through inhibition of progestin-driven BCL6 expression.SIN3A and SIN3B differentially regulate breast cancer metastasis.Prolactin-Stat5 signaling in breast cancer is potently disrupted by acidosis within the tumor microenvironment.CPSF6 is a Clinically Relevant Breast Cancer Vulnerability Target: Role of CPSF6 in Breast Cancer.Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.The prolactin receptor: Diverse and emerging roles in pathophysiology.17β-Estradiol and ICI182,780 Differentially Regulate STAT5 Isoforms in Female Mammary Epithelium, With Distinct Outcomes.

P2860

Q33631708-096A7772-307C-4075-9881-B33C696E4B31 Q33727501-C17C2B5B-605F-42DE-B18B-86ADD5D357BD Q33783277-EFA68CC8-16E0-4FEF-BDDC-2F99A899D9B2 Q34439395-2B84CAE7-6AFD-40CF-B81C-97980A6A34C3 Q36568290-B1ADD0F8-5B63-47EC-806F-0E3850378A89 Q36629985-95797392-AE77-4A73-8D29-5C96EBEB9963 Q36707715-E442D8D1-C6B9-40A6-9182-13FAFC86BAA6 Q36952878-1CC1CFD0-F867-40B3-A706-68358C909A0B Q37066490-A5F2BB7D-4D03-4C6A-A1CC-9A0F5CED3427 Q37144576-E3E3E821-9A2F-45F9-A1E0-66DF51071FB2 Q37306543-49A99F55-F966-459F-A2E3-393AEDE4C5D9 Q37320689-C7BF8C7C-17D7-4161-8B78-E40488A2B366 Q37331101-66437211-A950-49C3-89FB-93B19344865C Q37531336-496AF027-F8F4-4261-8B47-5463C702463B Q37554700-088D36A9-4141-4936-B11B-6DBAEF72633A Q37684611-B1BF9EDD-31FE-4CB2-89C6-3971E640FD40 Q37689956-AD372DAF-13AC-4E61-BE10-7F8F6BDA1ADF Q41041403-0909B39C-92AF-486D-8344-57F370781A03 Q42276714-EC20AAC8-26A1-4CEB-B4E8-D029540BCE6B Q47137743-833B6193-F760-44D7-BBA1-0B45F4BC715A Q55248584-2FBCF118-CAFD-404A-8CEF-1EEDC566B807

P2860

Low levels of Stat5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes

http://www.wikidata.org/entity/Q21195193

description

2012 nî lūn-bûn

@nan

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

name

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@ast

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en-gb

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@nl

type

label

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@ast

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en-gb

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@nl

prefLabel

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@ast

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en-gb

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@nl

P1433

Q21195193-7551788C-F213-4BB3-BA22-D8EC77225E6F

P1476

Q21195193-5291618D-0343-49D8-B56E-6D36E12D1017

P2093

Q21195193-002196BD-FA81-47CA-8850-364DD3DA11A1

Q21195193-015DB453-FA64-4F4F-B21D-6BD165F47190

Q21195193-0B237B8E-7DD1-46D4-BFFA-FBD46C540BDC

Q21195193-1550B1FC-7F8F-49FF-83F6-3BC30C941BB7

Q21195193-19FBEFDB-5445-4029-8B65-BCE68CDBE8A3

Q21195193-4983AA67-36EA-4A45-88E3-42A8DB4F0A4B

Q21195193-4D7B85D8-0125-46E2-9C0E-297BEF0BF0C5

Q21195193-51E929DA-BEBA-4EEB-BC40-C2FD12EAEB04

Q21195193-5A947FBF-CCA1-421E-ADEC-FC4AC9805EAD

Q21195193-624E38FF-AFFA-4876-AA13-7E3FEE75F19B

P2860

Q21195193-00D52DE7-00D4-4A13-8654-BDCA77B8423B

Q21195193-0976C0CB-576B-47F9-AF0B-B3F503536634

Q21195193-11A37B3F-1E80-4426-8573-64AB4E72B70D

Q21195193-12F2DED6-EF5C-4013-8198-902571717171

Q21195193-1611D0DB-C986-44D6-B003-BF96C19F37BE

Q21195193-1AC0A1AC-247B-4A6C-A2C8-0B6325699D68

Q21195193-28B1311A-8F68-4CC0-B2B5-331F6900F556

Q21195193-35943A47-7873-41C7-960C-AF96E0B8C6C4

Q21195193-39F33BBD-76A1-4592-8DB8-BCDCD0066339

Q21195193-3AEA10C7-6755-42B2-8375-245A86C47C2B

P2888

Q21195193-09FB63D0-1EAA-4457-B058-055DCD275DBB

P304

Q21195193-8EB70F22-191B-4416-95FA-9C3094FBD9E9

P31

Q21195193-55B69835-5110-4CA8-A118-1EBAA4B6451F

P3181

Q21195193-D1A51191-987C-4835-8F9B-5FC5021F7EA7

P356

Q21195193-0614E831-9ACC-409C-829A-A31029BDCFB6

P407

Q21195193-6F93EF58-FB52-43FC-8EFC-CAB86351C732

P433

Q21195193-0F5B6453-7BE7-4BE5-A2BA-7E7C75A6A628

P478

Q21195193-C6BC0E87-C9B6-4C54-97E8-CE778E921351

P50

Q21195193-9E28DEAF-1BA7-4472-8A32-7774EDECF322

P577

Q21195193-5F68C37A-9F07-4229-A547-52C1C8BA4185

P5875

Q21195193-6960FD37-EAC7-4B2E-9313-DEAFDA83C2FA

P6179

Q21195193-7F56E99A-3CB8-4F76-B477-99BA9CACD317

P698

Q21195193-7B345C8C-1230-4E5D-83CC-A86099E64E9D

P932

Q21195193-89955A66-ECD1-4B02-A7FB-1DA572D1EA3F

P3181

P356

P1433

Breast Cancer Research

P1476

Low levels of Stat5a protein i ...... unfavorable clinical outcomes

@en

P2093

Adam Ertel

http://www.w3.org/2001/XMLSchema#string

Agnieszka K Witkiewicz

http://www.w3.org/2001/XMLSchema#string

Albert J Kovatich

http://www.w3.org/2001/XMLSchema#string

Alexander C Klimowicz

http://www.w3.org/2001/XMLSchema#string

Amy R Peck

http://www.w3.org/2001/XMLSchema#string

Anne L Rosenberg

http://www.w3.org/2001/XMLSchema#string

Anthony M Magliocco

http://www.w3.org/2001/XMLSchema#string

Boris Freydin

http://www.w3.org/2001/XMLSchema#string

Chengbao Liu

http://www.w3.org/2001/XMLSchema#string

Craig D Shriver

http://www.w3.org/2001/XMLSchema#string

P2860

An absence of stromal caveolin-1 expression predicts early tumor recurrence and poor clinical outcome in human breast cancers

Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation

Signal transducer and activator of transcription 5A/B in prostate and breast cancers

A novel role for signal transducer and activator of transcription 5b (STAT5b) in beta1-integrin-mediated human breast cancer cell migration.

Signal transducer and activator of transcription 5b, c-Src, and epidermal growth factor receptor signaling play integral roles in estrogen-stimulated proliferation of estrogen receptor-positive breast cancer cells.

Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.

Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1.

Cloning and expression of Stat5 and an additional homologue (Stat5b) involved in prolactin signal transduction in mouse mammary tissue.

Nuclear IRS-1 predicts tamoxifen response in patients with early breast cancer.

Breast cancer prognostic classification in the molecular era: the role of histological grade.

P2888

P304

R130

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4354272

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/BCR3328

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-10-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

232085643

http://www.w3.org/2001/XMLSchema#string

P6179

1016865309

http://www.w3.org/2001/XMLSchema#string

P698

23036105

http://www.w3.org/2001/XMLSchema#string

P932

4053108

http://www.w3.org/2001/XMLSchema#string